Pharmacy Medical News about Stem Cells

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Plerixafor hydrochloride: A novel agent for the mobilization of peripheral blood stem cells
Drugs of Today, 11/05/09

Cashen AF – Plerixafor is a novel small molecule that inhibits CXCR4 binding to SDF–1, an interaction that is a principal regulator of hematopoietic stem cell trafficking. Phase I studies demonstrated that a single plerixafor hydrochloride dose results in a marked increase in white blood cell count and circulating CD34+ stem cells.

<< Previous
Quality of trials reported as conference abstracts in China: How...

Next >>
Solid-phase synthesis and biological activity of malformin C and...

Neural stem cell therapy in neurological diseases
Archives of Medical Science, 11/02/09 Relevance Score: 70%

The cancer stem cell microenvironment and anti-cancer therapy
International Journal of Radiation Biology, 11/05/09 Relevance Score: 69%

Aldehyde Dehydrogenase–Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
Cancer Research, 10/27/09 Relevance Score: 69%

Characterizing the HER2/neu Status and Metastatic Potential of Breast Cancer Stem/Progenitor Cells
Annals of Surgical Oncology, 10/20/09 Relevance Score: 69%

Autologous Fibrin-Cultured Limbal Stem Cells Permanently Restore the Corneal Surface of Patients With Total Limbal Stem Cell Deficiency
Transplantation, 10/06/09 Relevance Score: 69%